PSV 2022 Fall Meeting

Wintergreen Resort, Wintergreen VA
September 30-October 1, 2022

2022 Exhibitors

Plan to visit the exhibitors in the exhibit hall at the meeting! The Exhibits provide each attendee an opportunity to engage with exhibitors to learn about state-of-the-art medical products and services.


Exhibit Schedule

Friday, September 30, 2022
5:30 – 7:00 pm Welcome Reception with Legislators and Exhibitors (Exhibit Hall)
   
Saturday, October 1, 2022
7:15 – 8:00 am Breakfast with Exhibitors
10:30 – 11:00 am Coffee Break with Exhibitors
12:00 – 1:00 pm Lunch with Exhibitors

For exhibit information visit https://psva.org/fall-exhibitor-information/.

Click on the exhibitor/sponsor logo to view more information on the organization's website.


Gold Exhibitor


AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.




As the Program Administrator of the American Psychiatric Association endorsed Psychiatrists Medical Professional Liability Insurance program we provide an exceptional insurance policy with comprehensive protection, including ECT and forensic coverage, at competitive rates and with many benefits and discounts.  In addition, we are now offering a Cyber Liability Coverage endorsement at renewal and our policyholders have access to a team of knowledgeable and experienced Risk Management Experts for consultation and a 24-7 emergency hotline.   




Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.







Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. With patients at the center of everything it does, Sunovion has an unwavering commitment to support people with psychiatric, neurological and respiratory conditions. Visit us at www.sunovion.com.




 

As the global leader in generic medicine, nearly 200 million people across six continents take one of our products every day. We also invest hundreds of millions of dollars every year to help our scientists develop specialty and biopharmaceutical treatments that aim to increase access and improve patients’ health. Since Teva’s establishment in 1901 in Jerusalem, our leadership in healthcare has been marked by tenacity, entrepreneurial spirit, and an aspiration to improve people's lives.   This defines how we do business and motivates thousands of Teva employees all over the world, every single day.


Exhibitor



 

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.




Our Healthcare System
Centra Medical Group (CMG) is physician-led and comprised of 500+ physicians and advanced practice providers and serves 250,000 central and southern Virginians. Centra Healthcare System offers an integrated healthcare system, including 4 hospitals, 60+ physician practices, including primary care, medical and surgical specialists.
Our community Lynchburg (LYH) is a quintessential Virginian city with a leafy, historic veneer and an industrial heart. Its downtown and many neighborhoods offer a rich cultural character, a vital sense of the past and a growing contemporary energy. It attracts residents, companies, and visitors because it offers a revitalized and walkable downtown with eclectic shops and welcoming proprietors, a lushly green riverfront crisscrossed with trails and ways to explore, and opportunities in industries that are helping define the future. Our 80,000 residents are smart, young, and diverse.




 

Operating through 149 Company-operated treatment centers, Greenbrook is a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 840,000 TMS treatments to over 24,000 patients struggling with depression.




As one of the nation's leading providers of healthcare services, HCA Healthcare is comprised of 182 hospitals and 2,300+ sites of care in 20 states and the United Kingdom. As a learning health system, HCA Healthcare analyzes data from more than 35 million patient encounters each year to develop technologies and best practices that improve patient care. We also share our learnings with the larger healthcare community and government agencies to improve care everywhere.  At HCA Healthcare, we believe we are uniquely positioned to play a leading role in the transformation of care - at the beside and beyond. Connect with @HCAHealthcare  or Visit HCAHealthcare.com  for more.




Idorsia U.S., an affiliate of Idorsia, is reaching out for more – we have more ideas, we see more opportunities, and we want to help more patients. With commercial operations based outside of Philadelphia, PA, one of densest communities of life sciences talent in the world, we are helping to realize the company's ambition of bringing innovative medicines from bench to bedside. Our goal is to build a commercial footprint that will deliver Idorsia's deep pipeline of products from its R&D engine to the U.S. market – with the potential to change the lives of many patients.




We want to reduce the burden, disability and devastation caused by serious neuropsychiatric and neurodegenerative diseases.

Our mission is to develop new solutions and innovations that not only improve, but transform, the lives of people living with mental illness.

We are committed to improving the way in which mental health disorders are prevented, diagnosed and treated in order to change the lives of people living with mental illness.




CNS Company




PRMS® manages The Psychiatrists’ Program®, a full-service medical professional liability insurance program for behavioral healthcare providers. Unparalleled in its risk management expertise, aggressive defense strategies, and specialized policy, the program includes telepsychiatry and forensic coverage at no cost, and license defense coverage up to $150,000.*

*May vary by state.




Tris Pharma is a fully integrated, innovation-driven CNS company that provides a differentiated approach to target unmet medical needs, including the application of novel technologies designed to enhance patient benefits across therapeutic categories. Tris’s CNS portfolio includes treatments for pain; addiction; spasticity in multiple sclerosis, cerebral palsy; narcolepsy; and ADHD. For more information, please visit www.trispharma.com and www.trismedical.com.




One of the nation’s largest and most respected hospital companies, Universal Health Services, Inc. (NYSE: UHS) has built an impressive record of achievement and performance. Growing steadily since its inception into an esteemed Fortune 500 corporation, UHS today has annual revenues of $11.6 billion. In 2021, UHS was again recognized as one of the World’s Most Admired Companies by Fortune; in 2020, ranked #281 on the Fortune 500; and listed #330 in Forbes ranking of U.S.’ Largest Public Companies.

Our operating philosophy is as effective today as it was 40 years ago, enabling us to provide compassionate care to our patients and their loved ones: Build or acquire high quality hospitals in rapidly growing markets, invest in the people and equipment needed to allow each facility to thrive, and become the leading healthcare provider in each community we serve.

Headquartered in King of Prussia, PA, UHS has more than 89,000 employees and through its subsidiaries operates 350 inpatient acute care hospitals and behavioral health facilities and 30 outpatient and other facilities located in 38 states, Washington, D.C., Puerto Rico and the United Kingdom. For additional information on the Company, visit our web site: http://www.uhsinc.com.


Welcome Reception Sponsor